Surgical Critical Care: Renal Disease
Acute Kidney Injury (AKI) – Definition & Staging Systems
RIFLE Classification – Most Commonly Cited System
- Acute Rise in Cr Over 7 Days
- Risk of Renal Failure
- Increase in Serum Cr ≥ 1.5x Baseline
- Decrease in GFR ≥ 25% Baseline
- UOP < 0.5 cc/kg/hr for 6 Hours
- Injury of the Kidney
- Increase in Serum Cr ≥ 2.0x Baseline
- Decrease in GFR ≥ 50% Baseline
- UOP < 0.5 cc/kg/hr for 12 Hours
- Failure of the Kidney
- Increase in Serum Cr ≥ 3.0x Baseline or Cr ≥ 0.5 mg/dL if Bassline Cr ≥ 4 mg/dL
- Decrease in GFR ≥ 75% Baseline
- UOP < 0.3 cc/kg/hr for 24 Hours or Anuria for 12 Hours
- Loss of Kidney Function
- Complete Loss of Function ≥ 4 Weeks
- End-Stage Renal Disease
- Complete Loss of Function ≥ 3 Months
Acute Kidney Injury Network (AKIN) Classification
- Acute Rise in Cr Over 48 Hours
- Stage I
- Increase in Serum Cr ≥ 0.3 mg/dL
- Increase in Serum Cr ≥ 1.5x Baseline
- UOP < 0.5 cc/kg/hr for 6 Hours
- Stage II
- Increase in Serum Cr ≥ 2.0x Baseline
- UOP < 0.5 cc/kg/hr for 12 Hours
- Stage III
- Increase in Serum Cr ≥ 3.0x Baseline or Cr ≥ 0.5 mg/dL if Bassline Cr ≥ 4 mg/dL
- UOP < 0.3 cc/kg/hr for 24 Hours or Anuria for 12 Hours
- Initiation of Renal-Replacement Therapy (RRT)
Kidney Disease Improving Global Outcomes (KDIGO) Classification
- AKI Definition:
- Increase in Serum Cr ≥ 0.3 mg/dL within 48 Hours
- Increase in Serum Cr ≥ 1.5x Baseline within 7 Days
- UOP < 0.5 cc/kg/hr for 6 Hours
- Staging:
- Stage I
- Increase in Serum Cr ≥ 0.3 mg/dL
- Increase in Serum Cr ≥ 1.5x Baseline
- UOP < 0.5 cc/kg/hr for 6 Hours
- Stage II
- Increase in Serum Cr ≥ 2.0x Baseline
- UOP < 0.5 cc/kg/hr for 12 Hours
- Stage III
- Increase in Serum Cr ≥ 3.0x Baseline or Cr ≥ 4 mg/dL
- UOP < 0.3 cc/kg/hr for 24 Hours or Anuria for 12 Hours
- Initiation of Renal-Replacement Therapy (RRT)
- Stage I
Comparison
Stage | RIFLE | AKIN | KDIGO |
1 | Risk | Same as RIFLE Risk
Plus: Increase in Serum Cr ≥ 0.3 mg/dL Minus: GFR Criteria |
Same as AKIN Stage I |
2 | Injury | Same as RIFLE Injury
Minus: GFR Criteria |
Same as AKIN Stage II |
3 | Failure | Same as RIFLE Failure
Plus: Initiation of RRT Minus: GFR Criteria |
Same as AKIN Stage III
Change: Cr ≥ 0.5 mg/dL if Bassline Cr ≥ 4 mg/dL to Simply Cr ≥ 4 mg/dL |
- All Have the Same UOP Criteria
- Only RIFLE Uses GFR Criteria
Acute Kidney Injury (AKI)
Types & Causes
- Pre-Renal
- Low Blood Flow
- Dehydration
- Bleeding
- Congestive Heart Failure
- Sepsis
- Renal
- Acute Glomerulonephritis
- Infection
- Vasculitis
- Acute Tubular Necrosis (ATN)
- Ischemia
- Prolonged Hypotension
- Intraoperative Hypotension is the Most Common Cause of Post-Op AKI
- Toxins
- Contrast-Induced AKI
- Acute Interstitial Nephritis (AIN)
- Infection
- Drugs
- Inflammatory Disease
- Neoplasia
- Acute Glomerulonephritis
- Post-Renal
- Obstruction
- Urinary Stones
- Benign Prostatic Hypertrophy (BPH)
- Neoplasia
- Retroperitoneal Fibrosis
- Urethral Stricture
Laboratory Evaluation
- Fractional Excretion of Sodium (FENa)
- Best Test for Azotemia
- FENa = 100 x (UNa/PNa) / (UCr/PCr)
Pre-Renal | Renal | Post-Renal | |
BUN:Cr | > 20 | < 15 | Varies |
FENa | < 1% | 1-4% | ≥ 5% |
Urine Na | < 20 |
- Urinary Casts – Seen from Renal Causes
- Acute Glomerulonephritis – Protein & Red Blood Cell (RBC) Casts
- Acute Tubular Necrosis (ATN) – Granular & Muddy Brown Casts
- Acute Interstitial Nephritis (AIN) – Eosinophils & WBC Casts
Electrolyte Disturbances of Kidney Disease
- Increased
- Potassium
- Magnesium
- Phosphorus
- Decreased:
- Vitamin D & Calcium
- Erythropoietin & Hemoglobin
Treatment
- Management is Primarily Supportive
- Treat Underlying Cause
- Avoid Nephrotoxic Medications
- Volume Management:
- Crystalloid Fluid Resuscitation if Hypovolemic
- High-Dose Loop Diuretics May Be Required for Volume Overload if Not Anuric
- Manage Electrolyte & Acid-Base Disturbances
- Hyperkalemia is Generally the Most Immediate Threat in AKI
- Manage Nutrition
- Assess for Uremia
- Renal Replacement Therapy (RRT) if Indicated
Renal Replacement Therapy (RRT)
Indications Mn
- Acidosis (pH < 7.1)
- Electrolyte Disturbances
- Potassium > 6.5 mEq/L
- Potassium > 5.5 mEq/L with Tissue Breakdown (Rhabdomyolysis) or Ongoing Potassium Absorption (GI Bleed)
- Symptomatic Hyperkalemia (Cardiac Conduction Abnormality)
- Intoxicants/Poisoning
- Fluid Overload with Pulmonary Edema
- Symptomatic Uremia (Encephalopathy, Coagulopathy or Pericarditis)
- Renal Function Indications:
- Symptomatic & GFR < 15
- Asymptomatic & GFR < 5
Modalities
- Intermittent Hemodialysis (IHD)
- Rapid & Large Volume Shift
- Blood Flow: 300-400 cc/min
- Dialysate Flow: ≥ 500 cc/min
- Duration: 3-4 Hours – Often 3 Times Per Week
- Large Shifts Can Cause Hemodynamic Instability
- Does Not Require Anticoagulation
- Rapid & Large Volume Shift
- Continuous Renal Replacement Therapy (CRRT)
- Slow & Continuous Venovenous Hemodialysis (CVVHD)
- Blood Flow: 150-200 cc/min
- Dialysate Flow: 17-34 cc/min
- Duration: Continuous (24 Hours)
- Smaller Shifts Generally Do Not Cause Hemodynamic Instability – Best for Critically Ill Patients Who are Unable to Tolerate Hemodynamic Changes of IHD
- Not as Effective for Treatment of Severe Hyperkalemia as IHD
- Requires Anticoagulation – Can Lose 150 cc Blood if Filter Clots
- Slow & Continuous Venovenous Hemodialysis (CVVHD)
- Sustained Low-Efficiency Daily Dialysis (SLEDD)
- Considered a Hybrid of IHD & CRRT
- Slow Intermittent Flow Done More Frequently than IHD
- Blood Flow: 100-150 cc/min
- Dialysate Flow: 300 cc/min
- Duration: 6-12 Hours Every Day
- Smaller Shifts Generally Do Not Cause Hemodynamic Instability
- Usually Does Not Require Anticoagulation
- Early Initiation of RRT in AKI May Improve Survival (Debated)
Mnemonics
Basic Indications for Dialysis
- “A-E-I-O-U”
- Acidosis
- Electrolyte Disturbances
- Intoxicants/Poisoning
- Overloaded Fluid
- Uremia